NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

'There are some firms in NZ I won’t touch'
Policy

'There are some firms in NZ I won’t touch'

Adam Feeley on the reluctance to call out poor performers in NZ infrastructure sector.

Oliver Lewis 30 Jun 2025
Facebook is no place for risky financial investment offers
Opinion

Maria Slade: Facebook is no place for risky financial investment offers

Misleading ads continue to be thrust in the faces of Mum and Dad investors.

Maria Slade 30 Jun 2025
Where to take care of business in Fiji
Editor's Picks Free

Where to take care of business in Fiji

Sun, space, and seamless travel: Fiji’s pitch for NZ’s next big business meetings.

Riley Kennedy 28 Jun 2025
Former CBL CFO must pay $1.2m for disclosure breaches
Markets

Former CBL CFO must pay $1.2m for disclosure breaches

The case was a first for New Zealand courts, FMA says.

John Anthony 27 Jun 2025